ABAnil K. Bidani

Anil K. Bidani

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Anil K. Bidani has a total of 22 co-authors. Here are the top co-authors by number of shared publications:

  • Karen A. Griffin

    Division of Nephrology, Department of Medicine, Loyola University Medical Center and

    10 shared publications
  • Aaron J. Polichnowski

    Division of Nephrology, Department of Medicine, Loyola University Medical Center and

    4 shared publications
  • Rodger Loutzenhiser

    Smooth Muscle Research Group, University of Calgary, Calgary, Alberta, Canada

    3 shared publications
  • Geoffrey A. Williamson

    Department of Electrical and Computer Engineering, Illinois Institute of Technology, Chicago, Illinois

    2 shared publications
  • Geoffrey Williamson

    From the Department of Medicine, Loyola University Medical Center and Hines Veterans Affairs Hospital (A.K.B., K.A.G.), Maywood, Ill; Department of Electrical and Computer Engineering, Illinois Institute of Technology (G.W.), Chicago, Ill; and the Smooth Muscle Research Group, University of Calgary (X.W., R.L.), Calgary, Alberta, Canada

    2 shared publications
  • Jianrui Long

    Department of Electrical and Computer Engineering, Illinois Institute of Technology, Chicago, Illinois; and

    2 shared publications

Latest Publications

  • BP Fluctuations and the Real-Time Dynamics of Renal Blood Flow Responses in Conscious Rats

    by Anil K. Bidani, Aaron J. Polichnowski, Hector Licea-Vargas, Jianrui Long, Stephanie Kliethermes, Geoffrey A. Williamson, Karen A. Griffin

    Background Renal autoregulation maintains stable renal function despite BP fluctuations and protects glomerular capillaries from hypertensive injury. However, real-time dynamics of renal autoregulation in conscious animals have not been characterized. Methods To develop novel analytic methods for assessing renal autoregulation, we recorded concurrent BP and renal blood flow in conscious rats, comparing animals with renal autoregulation that was intact versus impaired (from 3/4 nephrectomy), before and after additional impairment (from the calcium channel blocker amlodipine). We calculated autoregulatory indices for adjacent short segments of increasing length (0.5, 1, 2.5, 5, 10, and 20 seconds) that exhibited a mean BP difference of at least 5 mm Hg. Results Autoregulatory restoration of renal blood flow to baseline after BP changes in conscious rats occurs rapidly, in 5–10 seconds. The response is significantly slower in states of impaired renal autoregulation, enhancing glomerular pressure exposure. However, in rats with severe renal autoregulation impairment (3/4 nephrectomy plus amlodipine), renal blood flow in conscious animals (but not anesthetized animals) was still restored to baseline, but took longer (15–20 seconds). Consequently, the ability to maintain overall renal blood flow stability is not compromised in conscious rats with impaired renal autoregulation. Conclusions These novel findings show the feasibility of renal autoregulation assessment in conscious animals with spontaneous BP fluctuations and indicate that transient increases in glomerular pressure may play a greater role in the pathogenesis of hypertensive glomerulosclerosis than previously thought. These data also show that unidentified mechanosensitive mechanisms independent of known renal autoregulation mechanisms and voltage-gated calcium channels can maintain overall renal blood flow and GFR stability despite severely impaired renal autoregulation.


  • Determinants of Hypertensive Renal Disease and Its Progression

    by Karen A. Griffin, Aaron J Polichnowski, Anil K. Bidani

  • The Role of Systemic Blood Pressure in the Progression of Chronic Kidney Disease

    by Karen A Griffin, Krishna Pothugunta, Aaron J Polichnowski, Anil K Bidani


  • Basic science

    by Anil K. Bidani, Karen A. Griffin


  • Severe Renal Mass Reduction Impairs Recovery and Promotes Fibrosis after AKI

    by Aaron J. Polichnowski, Rongpei Lan, Hui Geng, Karen A. Griffin, Manjeri A. Venkatachalam, Anil K. Bidani

    Preexisting CKD may affect the severity of and/or recovery from AKI. We assessed the impact of prior graded normotensive renal mass reduction on ischemia-reperfusion-induced AKI. Rats underwent 40 minutes of ischemia 2 weeks after right uninephrectomy and surgical excision of both poles of the left kidney (75% reduction of renal mass), right uninephrectomy (50% reduction of renal mass), or sham reduction of renal mass. The severity of AKI was comparable among groups, which was reflected by similarly increased serum creatinine (SCr; approximately 4.5 mg/dl) at 2 days, tubule necrosis at 3 days, and vimentin-expressing regenerating tubules at 7 days postischemia-reperfusion. However, SCr remained elevated compared with preischemia-reperfusion values, and more tubules failed to differentiate during late recovery 4 weeks after ischemia-reperfusion in rats with 75% renal mass reduction relative to other groups. Tubules that failed to differentiate continued to produce vimentin, exhibited vicarious proliferative signaling, and expressed less vascular endothelial growth factor but more profibrotic peptides. The disproportionate failure of regenerating tubules to redifferentiate in rats with 75% renal mass reduction associated with more severe capillary rarefaction and greater tubulointerstitial fibrosis. Furthermore, initially normotensive rats with 75% renal mass reduction developed hypertension and proteinuria, 2-4 weeks postischemia-reperfusion. In summary, severe (>50%) renal mass reduction disproportionately compromised tubule repair, diminished capillary density, and promoted fibrosis with hypertension after ischemia-reperfusion-induced AKI in rats, suggesting that accelerated declines of renal function may occur after AKI in patients with preexisting CKD.


  • Blood pressure-renal blood flow relationships in conscious angiotensin II- and phenylephrine-infused rats

    by Aaron J. Polichnowski, Karen A. Griffin, Jianrui Long, Geoffrey A. Williamson, Anil K. Bidani

    Chronic ANG II infusion in rodents is widely used as an experimental model of hypertension, yet very limited data are available describing the resulting blood pressure-renal blood flow (BP-RBF) relationships in conscious rats. Accordingly, male Sprague-Dawley rats ( n = 19) were instrumented for chronic measurements of BP (radiotelemetry) and RBF (Transonic Systems, Ithaca, NY). One week later, two or three separate 2-h recordings of BP and RBF were obtained in conscious rats at 24-h intervals, in addition to separate 24-h BP recordings. Rats were then administered either ANG II ( n = 11, 125 ng·kg−1·min−1) or phenylephrine (PE; n = 8, 50 mg·kg−1·day−1) as a control, ANG II-independent, pressor agent. Three days later the BP-RBF and 24-h BP recordings were repeated over several days. Despite similar increases in BP, PE led to significantly greater BP lability at the heart beat and very low frequency bandwidths. Conversely, ANG II, but not PE, caused significant renal vasoconstriction (a 62% increase in renal vascular resistance and a 21% decrease in RBF) and increased variability in BP-RBF relationships. Transfer function analysis of BP (input) and RBF (output) were consistent with a significant potentiation of the renal myogenic mechanism during ANG II administration, likely contributing, in part, to the exaggerated reductions in RBF during periods of BP elevations. We conclude that relatively equipressor doses of ANG II and PE lead to greatly different ambient BP profiles and effects on the renal vasculature when assessed in conscious rats. These data may have important implications regarding the pathogenesis of hypertension-induced injury in these models of hypertension.


  • Renal microvascular dysfunction, hypertension and CKD progression

    by Anil K. Bidani, Aaron J. Polichnowski, Rodger Loutzenhiser, Karen A. Griffin

    Purpose of review Despite apparent blood pressure (BP) control and renin–angiotensin system (RAS) blockade, the chronic kidney disease (CKD) outcomes have been suboptimal. Accordingly, this review is addressed to renal microvascular and autoregulatory impairments that underlie the enhanced dynamic glomerular BP transmission in CKD progression. Recent findings Clinical data suggest that failure to achieve adequate 24-h BP control is likely contributing to the suboptimal outcomes in CKD. Whereas evidence continues to accumulate regarding the importance of preglomerular autoregulatory impairment to the dynamic glomerular BP transmission, emerging data indicate that nitric oxide-mediated efferent vasodilation may play an important role in mitigating the consequences of glomerular hypertension. By contrast, the vasoconstrictor effects of angiotensin II are expected to potentially reduce glomerular barotrauma and possibly enhance ischemic injury. When adequate BP measurement methods are used, the evidence for BP-independent injury initiating mechanisms is considerably weaker and the renoprotection by RAS blockade largely parallels its antihypertensive effectiveness. Summary Adequate 24-h BP control presently offers the most feasible intervention for reducing glomerular BP transmission and improving suboptimal outcomes in CKD. Investigations addressed to improving myogenic autoregulation and/or enhancing nitric oxide-mediated efferent dilation in addition to the more downstream mediators may provide additional future therapeutic targets.


  • Blood-pressure targets in chronic kidney disease

    by Anil K. Bidani, Karen A. Griffin

    The optimal blood-pressure goals to prevent progression of chronic kidney disease (CKD) remain controversial. The results of the AASK cohort study provide additional support for more aggressive blood-pressure control (<130/90 mmHg) in proteinuric but not nonproteinuric patients with hypertensive CKD.


  • Protective Importance of the Myogenic Response in the Renal Circulation

    by Anil K. Bidani, Karen A. Griffin, Geoffrey Williamson, Xuemei Wang, Rodger Loutzenhiser


  • Spontaneously reduced blood pressure load in the rat streptozotocin-induced diabetes model: potential pathogenetic relevance

    by Anil K. Bidani, Maria Picken, Rifat Hacioglu, Geoffrey Williamson, Karen A. Griffin

    The rat streptozotocin (STZ)-induced diabetes model is widely used to investigate the pathogenesis of diabetic nephropathy. However, overt nephropathy is inexplicably slow to develop in this model compared with renal mass reduction (RMR) models. To examine whether blood pressure (BP) differences correlated with the time course of glomerulosclerosis (GS), BP was measured continuously throughout the course by radiotelemetry in control (n = 17), partially insulin-treated STZ-diabetes (average blood glucose 364 ± 15 mg/dl; n = 15), and two normotensive RMR models (systolic BP n = 16) and 3/4 RMR by surgical excision [right nephrectomy + excision of both poles of left kidney (RK-NX); n = 12] in Sprague-Dawley rats. Proteinuria and GS were assessed at ∼16–20 wk (all groups) and at 36–40 wk (all groups except RK-NX). At 16 wk, significantly greater proteinuria and GS had developed in the RK-NX group compared with the other three groups (not different from each other). By 36–40 wk, substantial proteinuria and GS had also developed in the UNX group, but both the control and the STZ-diabetic rats exhibited comparable modest proteinuria and minimal GS. Systolic BP (mmHg) was significantly reduced in the STZ-diabetic rats (116 ± 1.1) compared with both control (124 ± 1.0) and RMR (128 ± 1.2 and 130 ± 3.0) groups (P < 0.01). Similarly, “BP load” as estimated by BP power spectral analysis was also lower in the STZ-diabetic rats. Given the known protective effects of BP reductions on the progression of diabetic nephropathy, it is likely that this spontaneous reduction in ambient BP contributes to the slow development of GS in the STZ-diabetes model compared with the normotensive RMR models.